Filed by US BioEnergy Corporation

Pursuant to Rule 425 under the Securities Act of 1933, as amended

and deemed as filed pursuant to Rule 14a-12 under

the Securities Exchange Act of 1934, as amended

Subject Company: US BioEnergy Corporation

Commission File Number: 001-33203

I am pleased to announce the new Executive Management team of the combined VeraSun Energy Corporation following the merger with US BioEnergy. This is the group that will work through the details of the transition and eventually lead the company following the completion of the merger.

As you probably already know, Danny Herron, VeraSun’s current President and CFO, will serve as President of the combined company following the merger. Both Danny and Bill Honnef, VeraSun’s current Senior Vice President of Strategic Initiatives, will report directly to Don Endres, VeraSun’s CEO, going forward. I will be the Chairman of VeraSun’s Board of Directors following the merger.

The individuals who will report directly to Danny include:

   

Rich Atkinson, Senior Vice President and Chief Financial Officer

   

Greg Schlicht, Senior Vice President and General Counsel

   

Barry Schaps, Senior Vice President, Logistics

   

Paul Caudill, Senior Vice President, Operations

   

Bob Antoine, Senior Vice President, Human Resources

   

Chad Hatch, Senior Vice President, Corporate Development

The group has started meeting on a regular basis to develop plans to transition the two companies into one combined company. At this time, we still expect the merger to be completed in March.

We will do our very best to keep everyone informed throughout this process. I would also like to wish you and your families an enjoyable holiday and happy new year.

/s/ Gordon W. Ommen

Additional Information

In connection with the proposed transaction between VeraSun and US BioEnergy, VeraSun has filed a registration statement on Form
S-4 with the SEC. Such registration statement includes a preliminary joint proxy statement of VeraSun and US BioEnergy that also constitutes a preliminary prospectus of VeraSun. SHAREHOLDERS ARE URGED TO READ THE PRELIMINARY JOINT PROXY STATEMENT/PROSPECTUS AND ANY OTHER RELEVANT DOCUMENTS, INCLUDING THE DEFINITIVE JOINT PROXY STATEMENT/PROSPECTUS, WHEN THEY BECOME AVAILABLE, BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT VERASUN, US BIOENERGY AND THE PROPOSED TRANSACTION. The preliminary joint proxy statement/prospectus and other documents relating to the proposed transaction can be obtained free of charge from the SEC’s website at www.sec.gov . These documents can also be obtained free of charge from VeraSun upon written request to VeraSun Energy Corporation, Attention: Investor Relations, 100 22nd Avenue, Brookings, South Dakota 57006, or by calling 605-696-7236, or from US BioEnergy, upon written request


to US BioEnergy Corporation, Attention: Investor Relations, 5500 Cenex Drive, Inver Grove Heights, Minnesota 55077, or by calling 651-554-5491.

This communication is not a solicitation of a proxy from any security holder of VeraSun or US BioEnergy. However, VeraSun, US BioEnergy and certain of their respective directors and executive officers may be deemed to be participants in the solicitation of proxies from shareholders in connection with the proposed transaction under the rules of the SEC. Information about the directors and executive officers of VeraSun may be found in its 2006 Annual Report on Form 10-K filed with the SEC on March 29, 2007, definitive proxy statement relating to its 2007 Annual Meeting of Shareholders filed with the SEC on April 12, 2007 and current reports on Form 8-K filed with the SEC on July 3, 2007, August 31, 2007 and September 20, 2007. Information about the directors and executive officers of US BioEnergy may be found in its 2006 Annual Report on Form 10-K filed with the SEC on March 30, 2007, definitive proxy statement relating to its 2007 Annual Meeting of Shareholders filed with the SEC on April 27, 2007 and current reports on Form 8-K filed with the SEC on August 13, 2007, October 3, 2007 (as amended) and November 6, 2007. These documents can be obtained free of charge from the sources indicated above. Additional information regarding the interests of these participants is also included in the preliminary joint proxy statement/prospectus referred to above.

US Bioenergy Corp (MM) (NASDAQ:USBE)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more US Bioenergy Corp (MM) Charts.
US Bioenergy Corp (MM) (NASDAQ:USBE)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more US Bioenergy Corp (MM) Charts.